"' Biotron Limited "'( Biotron ) is an Australian biotechnology company based in Sydney, NSW . Biotron develops novel small molecule antiviral therapeutics targeting Hepatitis C and HIV . Biotron has identified a new class of viral proteins as targets for potential intervention, and is developing novel small molecule therapeutics that target these proteins, specifically the p7 protein of Hepatitis C and Vpu protein of HIV . Biotron s lead drug, BIT225, is in clinical development for treatment of both HIV and Hepatitis C, as well as the hard to treat HIV / Hepatitis C co-infected population.
12.
"' Biotron Limited "'( Biotron ) is an Australian biotechnology company based in Sydney, NSW . Biotron develops novel small molecule antiviral therapeutics targeting Hepatitis C and HIV . Biotron has identified a new class of viral proteins as targets for potential intervention, and is developing novel small molecule therapeutics that target these proteins, specifically the p7 protein of Hepatitis C and Vpu protein of HIV . Biotron s lead drug, BIT225, is in clinical development for treatment of both HIV and Hepatitis C, as well as the hard to treat HIV / Hepatitis C co-infected population.
13.
"' Biotron Limited "'( Biotron ) is an Australian biotechnology company based in Sydney, NSW . Biotron develops novel small molecule antiviral therapeutics targeting Hepatitis C and HIV . Biotron has identified a new class of viral proteins as targets for potential intervention, and is developing novel small molecule therapeutics that target these proteins, specifically the p7 protein of Hepatitis C and Vpu protein of HIV . Biotron s lead drug, BIT225, is in clinical development for treatment of both HIV and Hepatitis C, as well as the hard to treat HIV / Hepatitis C co-infected population.
